BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 27534388)

  • 21. Completely resected anaplastic thyroid carcinoma combined with adjuvant chemotherapy and irradiation is associated with prolonged survival.
    Haigh PI; Ituarte PH; Wu HS; Treseler PA; Posner MD; Quivey JM; Duh QY; Clark OH
    Cancer; 2001 Jun; 91(12):2335-42. PubMed ID: 11413523
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment and Prognosis of Anaplastic Thyroid Carcinoma: A Clinical Study of 50 Cases.
    Liu TR; Xiao ZW; Xu HN; Long Z; Wei FQ; Zhuang SM; Sun XM; Xie LE; Mu JS; Yang AK; Zhang GP; Fan Y
    PLoS One; 2016; 11(10):e0164840. PubMed ID: 27760217
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Survival and Prognostic Factors of Anaplastic Thyroid Carcinoma.
    Paunovic IR; Sipetic SB; Zoric GV; Diklic AD; Savic DV; Marinkovic J; Zivaljevic VR
    Acta Chir Belg; 2015 Jan; 115(1):62-7. PubMed ID: 27384898
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anaplastic thyroid cancer: Prognostic factors, patterns of care, and overall survival.
    Glaser SM; Mandish SF; Gill BS; Balasubramani GK; Clump DA; Beriwal S
    Head Neck; 2016 Apr; 38 Suppl 1():E2083-90. PubMed ID: 26894506
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Management of Anaplastic Thyroid Carcinoma: the Fruits from the ATC Research Consortium of Japan.
    Sugitani I; Onoda N; Ito KI; Suzuki S
    J Nippon Med Sch; 2018; 85(1):18-27. PubMed ID: 29540641
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anaplastic thyroid carcinoma: clinical outcome of 30 consecutive patients referred to a single institution in the past 5 years.
    Brignardello E; Gallo M; Baldi I; Palestini N; Piovesan A; Grossi E; Ciccone G; Boccuzzi G
    Eur J Endocrinol; 2007 Apr; 156(4):425-30. PubMed ID: 17389456
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of Timeliness of Resection and Thyroidectomy Margin Status on Survival for Patients with Anaplastic Thyroid Cancer: An Analysis of 335 Cases.
    Goffredo P; Thomas SM; Adam MA; Sosa JA; Roman SA
    Ann Surg Oncol; 2015 Dec; 22(13):4166-74. PubMed ID: 26271394
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Histopathologic Features and Clinical Outcome of Anaplastic Thyroid Carcinoma with a Minor Anaplastic Component.
    Wong KS; Lorch JH; Alexander EK; Marqusee E; Cho NL; Nehs MA; Doherty GM; Barletta JA
    Endocr Pathol; 2020 Sep; 31(3):283-290. PubMed ID: 32445173
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anaplastic thyroid cancer: a case report of a long term survival patient and review of literature data.
    Ursino S; Fiorica F; Stefanelli A; Pedriali M; Colosimo C; Cocuzza P; Mazzotti V; Taibi R; Cartei F; Greco C
    Eur Rev Med Pharmacol Sci; 2014; 18(9):1368-72. PubMed ID: 24867515
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment outcomes in anaplastic thyroid carcinoma: survival improvement in young patients with localized disease treated by combination of surgery and radiotherapy.
    Yau T; Lo CY; Epstein RJ; Lam AK; Wan KY; Lang BH
    Ann Surg Oncol; 2008 Sep; 15(9):2500-5. PubMed ID: 18581185
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Management of the compromised airway and role of tracheotomy in anaplastic thyroid carcinoma.
    Mani N; McNamara K; Lowe N; Loughran S; Yap BK
    Head Neck; 2016 Jan; 38(1):85-8. PubMed ID: 25215461
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic factors and treatment outcomes of 100 cases of anaplastic thyroid carcinoma.
    Akaishi J; Sugino K; Kitagawa W; Nagahama M; Kameyama K; Shimizu K; Ito K; Ito K
    Thyroid; 2011 Nov; 21(11):1183-9. PubMed ID: 21936674
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Optimal combination of treatment modality to increase survival in patients with anaplastic thyroid carcinoma: A STROBE compliant retrospective study.
    Lee JH; Ahn HK; Seok JY; Lee KC; Chun YS; Chung YS; Lee YD
    Medicine (Baltimore); 2018 Jun; 97(25):e11037. PubMed ID: 29923991
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Spanish consensus for the management of patients with anaplastic cell thyroid carcinoma.
    Gómez Sáez JM; Jiménez-Fonseca P; Santamaría Sandi J; Capdevila Castillón J; Navarro González E; Zafón Llopis C; Ramón Y Cajal Asensio T; Riesco Eizaguirre G; Grande Pulido E; Galofré Ferrater JC
    Endocrinol Nutr; 2015 Mar; 62(3):e15-22. PubMed ID: 25583658
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of combined treatment for anaplastic thyroid carcinoma: results of a multinstitutional retrospective analysis.
    Conzo G; Polistena A; Calò PG; Bononi P; Gambardella C; Mauriello C; Tartaglia E; Avenia S; Sanguinetti A; Medas F; de Toma G; Avenia N
    Int J Surg; 2014; 12 Suppl 1():S178-82. PubMed ID: 24866070
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anaplastic thyroid carcinoma: from clinicopathology to genetics and advanced therapies.
    Molinaro E; Romei C; Biagini A; Sabini E; Agate L; Mazzeo S; Materazzi G; Sellari-Franceschini S; Ribechini A; Torregrossa L; Basolo F; Vitti P; Elisei R
    Nat Rev Endocrinol; 2017 Nov; 13(11):644-660. PubMed ID: 28707679
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New Perspectives Regarding Anaplastic Thyroid Carcinoma Approach Improvement.
    Figueiredo AS; Andrea-Ferreira P
    Endocr Metab Immune Disord Drug Targets; 2018; 18(6):555-564. PubMed ID: 29886838
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thyroid anaplastic carcinoma: the impact of multimodality treatment on survival. The experience of a referral center for endocrine surgery.
    Polistena A; Monacelli M; Lucchini R; Triola R; Conti C; Avenia S; Sole Di Patrizi M; Barillaro I; Boccolini A; Sanguinetti A; Avenia N
    Minerva Chir; 2014 Oct; 69(5):261-9. PubMed ID: 25052058
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Factors Associated with Survival in Anaplastic Thyroid Carcinoma: A Multicenter Study from the ENDOCAN-TUTHYREF Network.
    Jannin A; Giudici F; de la Fouchardière C; Al Ghuzlan A; Wassermann J; Chougnet CN; Drui D; Godbert Y; Ilouz F; Bardet S; Zanetta S; Roudaut N; Batisse Lignier M; Groussin L; Klein M; Zerdoud S; Lamartina L; Baudin E; Decaussin-Petrucci M; Leteurtre E; Borson Chazot F; Do Cao C; Borget I; Hadoux J;
    Thyroid; 2023 Oct; 33(10):1190-1200. PubMed ID: 37855745
    [No Abstract]   [Full Text] [Related]  

  • 40. A multimodality therapeutic approach in anaplastic thyroid carcinoma: study on 39 patients.
    Busnardo B; Daniele O; Pelizzo MR; Mazzarotto R; Nacamulli D; Devido D; Mian C; Girelli ME
    J Endocrinol Invest; 2000 Dec; 23(11):755-61. PubMed ID: 11194710
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.